Review





Similar Products

fadraciclib  (MedChemExpress)
94
MedChemExpress fadraciclib
Fadraciclib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fadraciclib/product/MedChemExpress
Average 94 stars, based on 1 article reviews
fadraciclib - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
palbociclib  (MedChemExpress)
94
MedChemExpress palbociclib
Palbociclib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/palbociclib/product/MedChemExpress
Average 94 stars, based on 1 article reviews
palbociclib - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
fadraciclib (formerly cyc065  (Cyclacel Inc)
90
Cyclacel Inc fadraciclib (formerly cyc065
Clinical trials of selective CDK2 inhibitor with published results
Fadraciclib (Formerly Cyc065, supplied by Cyclacel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fadraciclib (formerly cyc065/product/Cyclacel Inc
Average 90 stars, based on 1 article reviews
fadraciclib (formerly cyc065 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
fadraciclib  (Cyclacel Inc)
90
Cyclacel Inc fadraciclib
Clinical trials of selective CDK2 inhibitor with published results
Fadraciclib, supplied by Cyclacel Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fadraciclib/product/Cyclacel Inc
Average 90 stars, based on 1 article reviews
fadraciclib - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
gsk 626616  (MedChemExpress)
94
MedChemExpress gsk 626616
Clinical trials of selective CDK2 inhibitor with published results
Gsk 626616, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/gsk 626616/product/MedChemExpress
Average 94 stars, based on 1 article reviews
gsk 626616 - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier
hy 16297a fadraciclib medchemexpress  (MedChemExpress)
95
MedChemExpress hy 16297a fadraciclib medchemexpress
Clinical trials of selective CDK2 inhibitor with published results
Hy 16297a Fadraciclib Medchemexpress, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hy 16297a fadraciclib medchemexpress/product/MedChemExpress
Average 95 stars, based on 1 article reviews
hy 16297a fadraciclib medchemexpress - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

Image Search Results


Clinical trials of selective CDK2 inhibitor with published results

Journal: Journal of Immunotherapy and Precision Oncology

Article Title: Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review

doi: 10.36401/JIPO-24-22

Figure Lengend Snippet: Clinical trials of selective CDK2 inhibitor with published results

Article Snippet: Fadraciclib (formerly CYC065) (Cyclacel, Berkely Heights, NJ) is a CDK2/9 inhibitor that was initially investigated with an intravenous formulation in a trial that was never published.

Techniques: Activity Assay

Ongoing clinical trials of selective CDK2 inhibitors without published results

Journal: Journal of Immunotherapy and Precision Oncology

Article Title: Cyclin Dependent Kinase 2 (CDK2) Inhibitors in Oncology Clinical Trials: A Review

doi: 10.36401/JIPO-24-22

Figure Lengend Snippet: Ongoing clinical trials of selective CDK2 inhibitors without published results

Article Snippet: Fadraciclib (formerly CYC065) (Cyclacel, Berkely Heights, NJ) is a CDK2/9 inhibitor that was initially investigated with an intravenous formulation in a trial that was never published.

Techniques: